Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Contact

Biomarker May Determine Chemotherapy Response in Mesothelioma

by Brayton Purcell LLP | Nov 16, 2015 | Mesothelioma

Recently, researchers determined that the serum protein, survivin, might help predict a patient’s mesothelioma treatment response. By testing the levels of the protein in 78 blood samples of mesothelioma patients, Slovenian researchers found that post-chemotherapy protein levels can help determine their response to treatment as well as their overall survival.

Blood samples were tested before and after chemotherapy, and when their mesothelioma tumor growth reoccurred. The researchers found that mesothelioma patients who had an increase in survivin levels after treatment tended to have a better chemotherapy response than those whose levels dropped. The patients with increased levels also tended to experience longer progression-free survival.

Given that the survival rates of mesothelioma patients can be so short, this is excellent news. Patients who are given one to two years to live after diagnosis should not have to waste precious time waiting to see if their treatment is working. This biomarker could help quickly and accurately determine if chemotherapy is a viable treatment option for the patient.

See our Treatment Options page to see what other mesothelioma treatments are available for patients.


Source: Surviving Mesothelioma

Recent Posts

  • EPA Risk Evaluation for Chrysotile Asbestos
  • Caring for Someone with Mesothelioma: What to Know
  • 2020 shows promise in the fight for a mesothelioma cure
  • Asbestos in Makeup Products Is a Problem That Is Not Going Away
  • How Did I Get Mesothelioma?

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us